Are computed-tomography-based hematoma radiomics features reproducible and predictive of intracerebral hemorrhage expansion? an in vitro experiment and clinical study.

Abstract

To identify reproducible hematoma radiomics features (RFs) for use in predicting hematoma expansion (HE) in patients with acute intracerebral hemorrhage (ICH). For test-retest analysis, three syringes with different volumes of blood collected at the same time (to mimic homogeneous hematoma) and a phantom (FT/HK 2000; Huake, Szechwan, China) containing three cylindrical inserts were scanned seven times within 6 h on the same CT scanner. Three additional syringes with mixed blood collected at different time points (to mimic heterogeneous hematoma) were tied together with the first three syringes as well as the phantom were scanned using modified CT acquisition parameters for intra CT analysis. A coefficient of variation below 10% served as the cutoff value for reproducibility. Finally, reproducible and potentially useful RFs were used to predict HE in 144 acute ICH patients, with the area under the receiver operating characteristic curves (AUC) used to evaluate their diagnostic performance. A total of 630 RFs including 18 first-order, 24 gray-level co-occurrence matrix (GLCM), 16 gray-level run length matrix (GLRLM), five neighborhood gray-tone difference matrix (NGTDM), 63 Laplacian of Gaussian (LoG), and 504 Wavelet features were evaluated. In the test-retest analysis, the percentages of reproducible RFs ranged from 42.54% (268/630) to 45.4% (286/630) for the three homogeneous hematoma samples and 79.05% (498/630) to 81.43% (513/630) for the phantom. In the intra-CT analysis, the percentages varied from 31.43% (198/630) to 42.38% (267/630) for the six hematoma samples and 48.89% (308/630) to 53.97% (340/630) for the phantom. In the in vitro experiment, 148 RFs were reproducible for all hematoma samples in both the test-retest and intra-CT analyses; however, only 80 were statistically different between homogeneous and heterogeneous hematoma samples. Finally, HE occurred in 25% (growth >6 ml, 36/144) to 31.94% (growth >3 ml or 33%, 46/144) of the patients. The AUCs in predicting HE ranged from 0.625 to 0.703. Only a few CT-based RFs from the in vitro hematoma were reproducible and can distinguish between homogeneous and heterogeneous hematomas. The use of RFs alone to predict HE in acute ICH showed only a moderate performance. Using an in vitro experiment and clinical validation, this study demonstrated for the first time that CT-based hematoma RFs can be used to predict HE in acute ICH; nonetheless, only a few RFs are reproducible and can be used for prediction.